Loading...
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
Saved in:
| Published in: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove Medical Press
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6352870/ https://ncbi.nlm.nih.gov/pubmed/30774311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S192124 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|